Privigen 10% vial 400ML
Ended Awarded
- Contract number
- SPE2DB25FCNAL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $79,416
Award facts
- Contract value 100% obligated
- $79,415.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $79,415.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for PRIVIGEN 10% Vial 400ML. This firm fixed-price delivery order, issued on September 15, 2025, with an ultimate completion date of October 6, 2025, carries no set-aside designation. The award leverages DMS Pharmaceutical Group's substantial Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical consumables supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of delivery orders from the DLA covering an extensive array of medical products including prescription medications, biologics, vaccines, and specialty pharmaceuticals. The company's experience distributing branded and generic drugs, over-the-counter medications, and medical consumables directly to Department of Defense healthcare sites positions it as a key distributor for federal military health system requirements. PRIVIGEN, an intravenous immunoglobulin therapy product, represents the type of specialized pharmaceutical product the vendor regularly delivers to support military medical operations.
Quick answers
Who was awarded contract SPE2DB25FCNAL?
SPE2DB25FCNAL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FCNAL worth?
The government has obligated $79,416 on SPE2DB25FCNAL.
Is contract SPE2DB25FCNAL an order under another contract?
Yes. SPE2DB25FCNAL is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCNAL competed?
The extent of competition for SPE2DB25FCNAL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award